[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340487-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-340487-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","metabolic-reprogramming-and-therapeutic-resistance-in-primary-and-metastatic-breast-cancer","Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer","","Metabolic alterations, a cancer hallmark, enable tumor cells to adapt by reshaping glucose, lipid, and amino-acid metabolism, thereby supporting rapid growth and treatment resistance. In primary breast cancer, metabolic shifts including the Warburg effect and increased lipid synthesis are linked to chemotherapy failure, while metastatic lesions show distinct metabolic profiles that maintain tumor progression and drive resistance to targeted therapies and immunotherapies. The review links mechanisms of metabolic resistance across primary and metastatic disease and highlights how metastatic microenvironments further complicate treatment.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/metabolic-reprogramming-and-therapeutic-resistance-in-primary-and-metastatic-breast-cancer/340487/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/metabolic-reprogramming-and-therapeutic-resistance-in-primary-and-metastatic-breast-cancer/340487.png","ImageObject",300,407,{"name":42,"@type":43},"Seraphina","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-13","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does metabolic alteration contribute to treatment resistance in breast cancer?","Question",{"text":63,"@type":64},"Metabolic alterations let tumor cells adapt their glucose, lipid, and amino-acid metabolism to sustain growth and create resistance during therapy. The review also connects these changes with resistance to chemotherapy, targeted therapy, and immunotherapy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What metabolic mechanisms are highlighted in primary breast cancer?",{"text":68,"@type":64},"The review emphasizes the Warburg effect and enhanced lipid synthesis as metabolic shifts that are closely associated with chemotherapy failure in primary breast cancer.",{"name":70,"@type":61,"acceptedAnswer":71},"Why do metastatic sites complicate treatment outcomes?",{"text":72,"@type":64},"Metastatic lesions often exhibit distinct metabolic profiles that not only sustain tumor growth but also confer resistance to targeted therapies and immunotherapies. The unique metastatic microenvironment further intensifies these challenges.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},340487,1790625094,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":102,"preview_urls":146},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","Liu et al. Molecular Cancer (2024) 23:261 [https://doi.org/10.1186/s12943-024-02165-x](https://doi.org/10.1186/s12943-024-02165-x)  \nMolecular Cancer  \n REVIEW Open Access  \nMetabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer  \nShan Liu1†, Xingda Zhang1†, Wenzheng Wang1†, Xue Li1†, Xue Sun1, Yuqian Zhao1, Qi Wang1, Yingpu Li 1*, Fangjie Hu2* and He Ren1*  \nAbstract  \nMetabolic alterations, a hallmark of cancer, enable tumor cells to adapt to their environment by modulating glucose, lipid, and amino acid metabolism, which fuels rapid growth and contributes to treatment resistance. In primary breast cancer, metabolic shifts such as the Warburg effect and enhanced lipid synthesis are closely linked to chemotherapy failure. Similarly, metastatic lesions often display distinct metabolic profiles that not only sustain tumor growth but also confer resistance to targeted therapies and immunotherapies. The review emphasizes two major aspects:  \nthe mechanisms driving metabolic resistance in both primary and metastatic breast cancer, and how the unique metabolic environments in metastatic sites further complicate treatment. By targeting distinct metabolic vulnerabilities at both the primary and metastatic stages, new strategies could improve the efficacy of existing therapies and provide better outcomes for breast cancer patients.  \nIntroduction  \nBreast cancer is the most commonly diagnosed malignancy among women worldwide and one of the leading causes of female mortality [1]. Based on the expression levels of hormone receptors (HR), human epidermal growth factor receptor 2 (HER2), and Ki-67, breast cancer can be classified into four molecular subtypes: HRpositive/HER2-negative, HR-positive/HER2-positive,  \n†Shan Liu, Xingda Zhang, Wenzheng Wang and Xue Li contributed equally to this work.  \n*Correspondence: Yingpu Li[liyingpu@hrbmu.edu.cn](liyingpu@hrbmu.edu.cn)[ ](liyingpu@hrbmu.edu.cn)Fangjie Hu [18846419361@163.com](18846419361@163.com)[ ](18846419361@163.com)He Ren [renhe@hrbmu.edu.cn](renhe@hrbmu.edu.cn)  \n1 Department of oncological surgery, Harbin Medical University Cancer Hospital, Harbin, China  \n2 Department of Gastroenterology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China  \nHR-negative/HER2-positive, and triple-negative breast cancer (TNBC) [2]. These subtypes exhibit distinct clinical features, biological behaviors, and responses to treatment. Despite advancements in surgery, radiotherapy, chemotherapy, and targeted therapies, significant challenges remain in breast cancer treatment, particularly with drug resistance. Resistance not only limits therapeutic efficacy but also promotes tumor recurrence and metastasis, increasing the risk of mortality. Therefore, understanding the molecular mechanisms of drug resistance and identifying effective methods to predict and reverse it is crucial for improving treatment outcomesand patient survival.  \nMetabolic reprogramming refers to the adjustment of cellular metabolic pathways in response to specific physiological or pathological conditions, enabling cells to adapt to environmental changes and support growth and survival [3]. The tumor microenvironment (TME) is a complex system comprising tumor cells, immune cells, vascular cells, stromal cells, and the extracellular matrix [4]. Within the TME, tumor cells interact with  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article ar","cbCaioYIHkv9K0Gr","https://ap.wps.com/l/cbCaioYIHkv9K0Gr","pdf",4377100,57,"English","# Abstract\n# Introduction\n## Molecular subtypes of breast cancer\n## Drug resistance and clinical challenges\n## Metabolic reprogramming and tumor microenvironment\n## Warburg effect and immune metabolic adaptation","[{\"question\":\"How does metabolic alteration contribute to treatment resistance in breast cancer?\",\"answer\":\"Metabolic alterations let tumor cells adapt their glucose, lipid, and amino-acid metabolism to sustain growth and create resistance during therapy. The review also connects these changes with resistance to chemotherapy, targeted therapy, and immunotherapy.\"},{\"question\":\"What metabolic mechanisms are highlighted in primary breast cancer?\",\"answer\":\"The review emphasizes the Warburg effect and enhanced lipid synthesis as metabolic shifts that are closely associated with chemotherapy failure in primary breast cancer.\"},{\"question\":\"Why do metastatic sites complicate treatment outcomes?\",\"answer\":\"Metastatic lesions often exhibit distinct metabolic profiles that not only sustain tumor growth but also confer resistance to targeted therapies and immunotherapies. The unique metastatic microenvironment further intensifies these challenges.\"}]","Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer | PDF",1790036838,144,[147,151,155,159,163,167],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3316b755ecc4659838ee96994259d6ad.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2352d107703191fe39b3ff1a2ce1affe.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b4cdaae13740ec8f7216e739796a05d.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1229450231d96a811f09a523a3cec780.webp",980,1301,{"page_no":97,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3eae5fe0a72b7ebb1d5cf73cdb9e3916.webp",979,1300,{"page_no":102,"url":168,"width":169,"height":170},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee0c93aed948193d36f35d88e6259656.webp",978,1299]